BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 24385810)

  • 41. Predictive value of integrin α7 for acute myeloid leukemia risk and its correlation with prognosis in acute myeloid leukemia patients.
    Zeng M; Ding S; Zhang H; Huang Q; Ren Y; Guo P
    J Clin Lab Anal; 2020 Apr; 34(4):e23151. PubMed ID: 31855276
    [TBL] [Abstract][Full Text] [Related]  

  • 42. AC133 antigen as a prognostic factor in acute leukemia.
    Lee ST; Jang JH; Min YH; Hahn JS; Ko YW
    Leuk Res; 2001 Sep; 25(9):757-67. PubMed ID: 11489469
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Expression of the C-kit receptor (CD117) is a feature of almost all subtypes of de novo acute myeloblastic leukemia (AML), including cytogenetically good-risk AML, and lacks prognostic significance.
    Schwartz S; Heinecke A; Zimmermann M; Creutzig U; Schoch C; Harbott J; Fonatsch C; Löffler H; Büchner T; Ludwig WD; Thiel E
    Leuk Lymphoma; 1999 Jun; 34(1-2):85-94. PubMed ID: 10350335
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Clinical value of CD25/CD123 co-expression in acute myeloid leukemia patients.
    Aref S; Azmy E; El Ghannam D; Haroun M; Ibrahim L; Sabry M
    Cancer Biomark; 2020; 29(1):9-16. PubMed ID: 32417762
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Prognostic significance of HOXB4 in de novo acute myeloid leukemia.
    Umeda S; Yamamoto K; Murayama T; Hidaka M; Kurata M; Ohshima T; Suzuki S; Sugawara E; Kawano F; Kitagawa M
    Hematology; 2012 May; 17(3):125-31. PubMed ID: 22664110
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Overexpression of the major vault transporter protein lung-resistance protein predicts treatment outcome in acute myeloid leukemia.
    List AF; Spier CS; Grogan TM; Johnson C; Roe DJ; Greer JP; Wolff SN; Broxterman HJ; Scheffer GL; Scheper RJ; Dalton WS
    Blood; 1996 Mar; 87(6):2464-9. PubMed ID: 8630412
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Gene Expression of VEGF-A and VEGF-C in Peripheral Blood Mononuclear Cells of Iranian Patients with Acute Myeloid Leukemia.
    Aliparasti MR; Almasi S; Sanaat Z; Movasaghpoor A; Khalili-Dizaji R; Sadeghi-Bazargani H
    Turk J Haematol; 2013 Jun; 30(2):137-43. PubMed ID: 24385776
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Upregulation of microRNA-100 predicts poor prognosis in patients with pediatric acute myeloid leukemia.
    Bai J; Guo A; Hong Z; Kuai W
    Onco Targets Ther; 2012; 5():213-9. PubMed ID: 23055746
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Expression of Lysosomal Membrane Proteins LAMP1, TPC1 and TPC2 in Acute Myeloid Leukemia Cells and Its Clinical Significance].
    Wang X; Ling BQ; Dai MF; Wang XB
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2019 Aug; 27(4):1046-1052. PubMed ID: 31418355
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The significance of trilineage myelodysplasia in de novo acute myeloblastic leukemia: clinical and laboratory features.
    Lima CS; Vassalo J; Lorand-Metze I; Bechelli AP; Souza CA
    Haematologia (Budap); 1997; 28(2):85-95. PubMed ID: 9283908
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Modulation of multidrug resistance by BIBW22BS in blasts of de novo or relapsed or persistent acute myeloid leukemia ex vivo.
    Schröder J; Esteban M; Müller MR; Kasimir-Bauer S; Bamberger U; Heckel A; Seeber S; Scheulen ME
    J Cancer Res Clin Oncol; 1996; 122(5):307-12. PubMed ID: 8609155
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Methylation-independent ITGA2 overexpression is associated with poor prognosis in de novo acute myeloid leukemia.
    Lian XY; Zhang W; Wu DH; Ma JC; Zhou JD; Zhang ZH; Wen XM; Xu ZJ; Lin J; Qian J
    J Cell Physiol; 2018 Dec; 233(12):9584-9593. PubMed ID: 30132837
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Overexpression of Bcl2 protein predicts chemoresistance in acute myeloid leukemia: its correlation with FLT3.
    Mehta SV; Shukla SN; Vora HH
    Neoplasma; 2013; 60(6):666-75. PubMed ID: 23906301
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Morphologic dysplasia in de novo acute myeloid leukemia (AML) is related to unfavorable cytogenetics but has no independent prognostic relevance under the conditions of intensive induction therapy: results of a multiparameter analysis from the German AML Cooperative Group studies.
    Haferlach T; Schoch C; Löffler H; Gassmann W; Kern W; Schnittger S; Fonatsch C; Ludwig WD; Wuchter C; Schlegelberger B; Staib P; Reichle A; Kubica U; Eimermacher H; Balleisen L; Grüneisen A; Haase D; Aul C; Karow J; Lengfelder E; Wörmann B; Heinecke A; Sauerland MC; Büchner T; Hiddemann W
    J Clin Oncol; 2003 Jan; 21(2):256-65. PubMed ID: 12525517
    [TBL] [Abstract][Full Text] [Related]  

  • 55. High expression of bcl-2 mRNA as a determinant of poor prognosis in acute myeloid leukemia.
    Karakas T; Maurer U; Weidmann E; Miething CC; Hoelzer D; Bergmann L
    Ann Oncol; 1998 Feb; 9(2):159-65. PubMed ID: 9553660
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Low miR-34c expression is associated with poor outcome in de novo acute myeloid leukemia.
    Yang DQ; Zhou JD; Wang YX; Deng ZQ; Yang J; Yao DM; Qian Z; Yang L; Lin J; Qian J
    Int J Lab Hematol; 2017 Feb; 39(1):42-50. PubMed ID: 27577964
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Vascular endothelial growth factor, a possible paracrine growth factor in human acute myeloid leukemia.
    Fiedler W; Graeven U; Ergün S; Verago S; Kilic N; Stockschläder M; Hossfeld DK
    Blood; 1997 Mar; 89(6):1870-5. PubMed ID: 9058706
    [TBL] [Abstract][Full Text] [Related]  

  • 58. In vivo administration of vascular endothelial growth factor (VEGF) and its antagonist, soluble neuropilin-1, predicts a role of VEGF in the progression of acute myeloid leukemia in vivo.
    Schuch G; Machluf M; Bartsch G; Nomi M; Richard H; Atala A; Soker S
    Blood; 2002 Dec; 100(13):4622-8. PubMed ID: 12453880
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Ph1-positive acute myeloid leukemia de novo or blast crisis of chronic myeloid leukemia? Molecular analysis and clinical course of a case].
    Colleoni GW; Satake M; Borovik CL; Kerbauy J; Yamamoto M
    Rev Assoc Med Bras (1992); 1998; 44(3):253-5. PubMed ID: 9755556
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Diagnostic Value of miR-34a in Bone Marrow Mononuclear Cells of Acute Myeloid Leukemia Patients.
    Liu X; Li H
    Clin Lab; 2020 Mar; 66(3):. PubMed ID: 32162890
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.